Blood Culture Test Market Revenue Drivers, Growth Opportunities, Supply Chain Analysis and Forecast Research Report Till 2025
“Global Blood Culture Test Market is projected to reach USD 6.6 billion by 2025 owing to prevalence of blood infections and infectious diseases.”
The global Blood Culture Test Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: Global Blood Culture Test Market is projected to reach USD 6.6 billion by 2025 owing to prevalence of blood infections and infectious diseases. Blood culture is a laboratory test wherein the patient’s blood is injected in bottles that contain culture media to determine the existence of infection-producing microorganisms like fungi or bacteria in the patient’s blood. It aims at confirming the existence of microorganisms in the blood, identifying the microbial etiology of the blood infection, helping to determine the infection source like endocarditis, and providing an organism for suspicion of testing and optimization of antimicrobial therapy. Key Players:
Becton, Dickinson and Company bioMérieux SA Thermo Fisher Scientific, Inc. Danaher Corporation Luminex Corporation Roche Diagnostics Bruker Corporation Abbott